Impax Laboratories, Inc.announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted...
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. has announced the resubmission of Impax's New Drug Application (NDA) for Rytary...
Impax Laboratories has announced that the European Commission (EC) has granted marketing authorization for Numient (Levodopa and Carbidopa), a modified-release...
The FDA has approved Rytary (extended-release oral carbidopa-levodopa), from Impax Pharma, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and...
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. has announced that the FDA has issued a Complete Response Letter regarding...
Allergan has filed an Abbreviated New Drug Application with the FDA seeking approval to market carbidopa and levodopa extended-release capsules,...